Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
||||||||
 |
 |
|||||||
|
20 April 2004 Cyprotex appoints non-executive Director from Genentech Cyprotex plc announces today that David Evans has been appointed to the Board of Directors as a non-executive Director with immediate effect. David is a member of the intellectual property group at Genentech, Inc., one of the world's leading biotherapeutics companies. David has worked with cutting edge biopharmaceutical companies for the past 13 years, including BioChem Pharma, Allelix Biopharmaceuticals which was acquired by NPS Pharmaceuticals, and currently Genentech, Inc. of South San Francisco. David holds a Bachelor of Science degree from the University of Toronto in chemistry and biology and began his career in intellectual property at the Canadian Patent Office in 1991. David Evans commented on his new role: "I see pharmacokinetic and ADME services as a high-growth area. Having worked with Robert it was exciting to hear that he was involved with Cyprotex and I am delighted to join him in helping the company grow further." Commenting on the appointment of David Evans, Robert Morrisson Atwater, Chairman and Chief Executive Officer of Cyprotex, said: "On behalf of the Board, I would like to welcome David Evans to the Company. I have known David personally for a number of years and have seen first hand his capabilities from my time spent at BioChem Pharma. He will become an important asset here at Cyprotex." Matters for disclosure under paragraph (f) of Schedule 2 of the AIM Rules with respect to the appointment of David Evans as a Director of Cyprotex plc:
There are no other matters that are required to be announced with regards to this appointment. For further information: Cyprotex PLC Robert Morrisson Atwater, Chairman & Chief Executive Officer Tel: +44 (0) 1625 505100 ir@cyprotex.com www.cyprotex.com Media enquiries: Bankside Henry Harrison-Topham / Heather Salmond Tel: +44 (0) 20 7444 4140 heather.salmond@bankside.com www.bankside.com |
||||||||
|
 |
|
